NOVARTIS AG DRNNOVARTIS AG DRNNOVARTIS AG DRN

NOVARTIS AG DRN

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.31 T‬BRL
40.974BRL
‪71.79 B‬BRL
‪302.49 B‬BRL
‪1.69 B‬
Beta (1Y)
0.90

About NOVARTIS N


CEO
Vasant Narasimhan
Headquarters
Basel
Founded
1996
ISIN
BRN1VSBDR006
FIGI
BBG00XX9KCR3
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Check out other big names from the same industry as N1VS34.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
N
NVS5894399
Novartis Capital Corp. 4.0% 18-SEP-2031
Yield to maturity
Maturity date
Sep 18, 2031
N
NVS4950565
Novartis Capital Corp. 2.0% 14-FEB-2027
Yield to maturity
Maturity date
Feb 14, 2027
N
NVS3904288
Novartis Capital Corp. 3.7% 21-SEP-2042
Yield to maturity
Maturity date
Sep 21, 2042
N
NVS5894398
Novartis Capital Corp. 3.8% 18-SEP-2029
Yield to maturity
Maturity date
Sep 18, 2029
N
NVS5894400
Novartis Capital Corp. 4.2% 18-SEP-2034
Yield to maturity
Maturity date
Sep 18, 2034
A3LZ2R
NOVARTIS INC 2024-18.06.31 REG S
Yield to maturity
Maturity date
Jun 18, 2031
N
NVS5894401
Novartis Capital Corp. 4.7% 18-SEP-2054
Yield to maturity
Maturity date
Sep 18, 2054
CH135325780
NOVARTIS 24/27
Yield to maturity
Maturity date
Jun 18, 2027
CH135325783
NOVARTIS 24/40
Yield to maturity
Maturity date
Jun 18, 2040
N
US66989HAH1
NOVARTIS CAPITAL 14/44
Yield to maturity
Maturity date
May 6, 2044
N
XS223599621
NOVARTIS FI. 20/28
Yield to maturity
Maturity date
Sep 23, 2028

See all N1VS34 bonds